MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1183/13993003.00462-2016

Медицинская библиотека · The European respiratory journal · 2016

Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.

Mitnick Carole D, White Richard A, Lu Chunling, Rodriguez Carly A, Bayona Jaime, Becerra Mercedes C, Burgos Marcos, Centis Rosella, Cohen Theodore, Cox Helen, D'Ambrosio Lia, Danilovitz Manfred, Falzon Dennis, Gelmanova Irina Y, Gler Maria T, Grinsdale Jennifer A, Holtz Timothy H, Keshavjee Salmaan, Leimane Vaira, Menzies Dick, Migliori Giovanni Battista, Milstein Meredith B, Mishustin Sergey P, Pagano Marcello, Quelapio Maria I, Shean Karen, Shin Sonya S, Tolman Arielle W, van der Walt Martha L, Van Deun Armand, Viiklepp Piret, Collaborative Group for Analysis of Bacteriology Data in MDR-TB Treatment

СтатьяМетаанализПоддержка правительства СШАПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Debate persists about monitoring method (culture or smear) and interval (monthly or less frequently) during treatment for multidrug-resistant tuberculosis (MDR-TB). We analysed existing data and estimated the effect of monitoring strategies on timing of failure detection.We identified studies reporting microbiological response to MDR-TB treatment and solicited individual patient data from authors. Frailty survival models were used to estimate pooled relative risk of failure detection in the last 12 months of treatment; hazard of failure using monthly culture was the reference.Data were obtained for 5410 patients across 12 observational studies. During the last 12 months of treatment, failure detection occurred in a median of 3 months by monthly culture; failure detection was delayed by 2, 7, and 9 months relying on bimonthly culture, monthly smear and bimonthly smear, respectively. Risk (95% CI) of failure detection delay resulting from monthly smear relative to culture is 0.38 (0.34-0.42) for all patients and 0.33 (0.25-0.42) for HIV-co-infected patients.Failure detection is delayed by reducing the sensitivity and frequency of the monitoring method. Monthly monitoring of sputum cultures from patients receiving MDR-TB treatment is recommended. Expanded laboratory capacity is needed for high-quality culture, and for smear microscopy and rapid molecular tests.

Для цитирования: Mitnick Carole D, White Richard A, Lu Chunling, Rodriguez Carly A, Bayona Jaime, Becerra Mercedes C, Burgos Marcos, Centis Rosella, Cohen Theodore, Cox Helen, D'Ambrosio Lia, Danilovitz Manfred, Falzon Dennis, Gelmanova Irina Y, Gler Maria T, Grinsdale Jennifer A, Holtz Timothy H, Keshavjee Salmaan, Leimane Vaira, Menzies Dick, Migliori Giovanni Battista, Milstein Meredith B, Mishustin Sergey P, Pagano Marcello, Quelapio Maria I, Shean Karen, Shin Sonya S, Tolman Arielle W, van der Walt Martha L, Van Deun Armand, Viiklepp Piret, Collaborative Group for Analysis of Bacteriology Data in MDR-TB Treatment. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method.. The European respiratory journal. 2016. DOI: 10.1183/13993003.00462-2016.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.